or search on
|Title:||Cancer risk among 21st century blood transfusion recipients|
|Authors:||Yang TO; Beral V; Cairns BJ; Reeves GK; Green J; for the Million Women Study Collaborators (incl. Canfell K)|
|Categories:||Early Detection, Diagnosis, and Prognosis - Technology and/or Marker Testing in a Clinical Setting|
Cancer Type - Non-Hodgkins Lymphoma
Cancer Type - Liver Cancer
|Journal Title:||Annals of Oncology|
|Page number start:||393|
|Page number end:||399|
|Abstract:||BACKGROUND: Some carcinogenic viruses are known to be transmissible by blood transfusion. Intensive viral screening of transfused blood now exists in most countries. In the UK, high-sensitivity nucleic acid amplification tests for hepatitis C virus were introduced in 1999 and it was thought that this would reduce, and possibly eliminate, transfusion-related liver cancer. We aimed to investigate cancer risk in recipients of blood transfusion in 2000 or after. METHODS: A total of 1.3 million UK women recruited in 1998 on average were followed for hospital records of blood transfusion and for cancer registrations. After excluding women with cancer or precancerous conditions before or at the time of transfusion, Cox regression yielded adjusted relative risks of 11 site-specific cancers for women with compared to without prior blood transfusion. RESULTS: During follow up, 11 274 (0.9%) women had a first recorded transfusion in 2000 or after, and 1648 (14.6%) of them were subsequently diagnosed with cancer, a mean 6.8 years after the transfusion. In the first 5 years after transfusion there were significant excesses for most site-specific cancers examined, presumably because some had preclinical cancer. However, 5 or more years (mean 8 years) after blood transfusion, there were significant excess risks only for liver cancer (adjusted relative risk = 2.63, 95%CI 1.45-4.78) and for non-Hodgkin lymphoma (adjusted relative risk = 1.74, 1.21-2.51). When analyses were restricted to those undergoing hip or knee replacement surgery, the commonest procedure associated with transfusion, these relative risks were not materially altered. CONCLUSIONS: In a large cohort of UK women, transfusions in the 21st century were associated with long-term increased risks of liver cancer and non-Hodgkin lymphoma. Some of these malignancies may have been caused by carcinogenic agents that are not currently screened for in transfused blood.|
|Division:||Cancer Research Division|
|Funding Body:||The Million Women Study is funded by Medical Research Council and Cancer Research UK (Cancer Research UK: C570/A16491, Medical Research Council: MR/K02700X/1). KC was supported by a NHMRC Fellowship (GNT1082989)|
|Appears in Collections:||Research Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.